Thrombectomy in addition to thrombolysis for medium distal vessel occlusions - results from the SITS registry
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Endovascular thrombectomy (EVT) is standard of care for acute ischemic stroke (AIS) caused by large vessel occlusion. Medium distal vessel occlusions (MDVO) account for 25-40% AIS cases, but recanalization rates with intravenous thrombolysis (IVT) are often below 50%. Studies have shown mixed results comparing EVT with best medical management in different MDVO populations. This study aims to show if EVT in addition to IVT is associated with clinical benefits or harm in patients with MDVO.
Methods
We performed an observational study of patients in the Safe Implementation of Treatments of Stroke International Stroke Registry (SITS-ISTR) 2016–23, treated with IVT or IVT+EVT for occlusion of the ACA, PCA or distal MCA (M3 and more distal). Outcomes were modified Rankin Scale score (mRS), death at 3 months, and post-treatment hemorrhage. Inverse probability treatment weighting and binomial logistic regression was performed due to baseline imbalances (age, NIHSS and occlusion site).
Results
Of 2198 included patients, 1903 (87%) received IVT, and 295 (13%) IVT+EVT. IVT+EVT patients were younger (73 vs 75) and had higher median NIHSS: 10 (IQR 6-15) vs 8 (5-12), p<0.001. The most common occlusion site was PCA in the IVT+EVT group, (n=179, 60.7%), and distal MCA (n=1140, 59.9%) in the IVT group. Rates of symptomatic intracerebral hemorrhage (SICH) were higher in the IVT+EVT group (SICH NINDS: 7.6% vs 3.5%, p=0.003; SICH ECASS-II: 5.4% vs 2.4%, p=0.011). After adjustment, IVT+EVT was associated with worse outcomes compared to IVT alone (aOR, 95% CI); mRS 0-1: 0.63 (0.44-0.90), mRS 0-2: 0.64 (0.44-0.91) and death: 2.03 (1.26-3.27).
Conclusions
IVT+EVT for MDVO was associated with worse outcomes compared to IVT alone. Results should be interpreted with caution due to retrospective observational design, warranting further randomized studies, but are in line with recently published RCTs
